Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Superdrug slashes aspirin price by 40% amid 'cost of living crisis'

The multiple has cut the prices of pain medication in the UK so products are more affordable during the cost of living crisis, it has announced.

Superdrug has cut the price of its own brand aspirin tablets by 40% to £0.29 to make pain medication more affordable during the "continued cost of living crisis", it announced today (July 17).

The multiple said that the price drop is effective from today across all UK stores, with the new pricing also applied to some branded pain relief products.

Jonathan Fairclough, Superdrug’s head of trading retail health, said that the health and beauty giant "wanted to reduce the prices of key pain relief products to hopefully make things a little easier for those who rely on such products to...go about their everyday lives”.

Read more: Superdrug reveals supercharged £112m profits in 2023 as it opens new branches

The other big price cuts include Bells ibuprofen tablets, which have dropped 29% to £0.39, and Anadin Extra reduced by 21% to £1.49, Superdrug said.

The health and beauty giant also applied small reductions to Panadol tablets and Voltarol Emulgels, as well as its own brand paracetamol solution and children’s pain relief products, while Calpol 80ml suspension was reduced to £3.29, it added.

It claimed that the move means it now offers the "UK high street's cheapest pain medication".

 

“Accessible for millions”

 

The multiple said it wanted pain medication to be “accessible for millions of people who regularly suffer from pain”, after it launched other cost-of-living initiatives such as its VIP Rewards loyalty scheme and removing 20% from its own brand sun care range.

It comes as Superdrug’s annual report released earlier this month showed that it raked in £1.5 billion in revenue and £112 million profits in 2023 as it plans to open 25 new branches this year.

Read more: Weight loss: Superdrug expands online Mounjaro service to high street

The hight street store also last week reported a 209% rise in sales of magnesium tablets to combat the UK's "summer of stress" due to Euro 2024, the general election and changeable weather.

And the multiple revealed in May that headlice spray sales spiked by 121% as it warned that “recent warmer weather” had caused a surge in headlice infestations.

Related Content

Topics

         
Qualified Pharmacy Assistant - Digital Pharmacy
Stoke-on-Trent, Staffordshire
£11.56 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD138364

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel